Lenalidomide-associated tumor flare reaction is manageable in patients with chronic lymphocytic leukemia.
Chanan-Khan
Asher A
AA
Whitworth
Amy
A
Bangia
Naveen
N
Porter
Carl W
CW
Lee
Kelvin
K
D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D000077269:Lenalidomide; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*; D015275:Tumor Lysis Syndrome / Q000209:etiology*
D018906:Antineoplastic Agents, Alkylating; D013792:Thalidomide; D000077269:Lenalidomide